Tech Company M&A Transactions
Ambion Acquisition
On 3/2/2006, Ambion was bought by Applied Biosystems Group. Deal value was $273 million.
Transaction Overview
Company Name
Acquired By
Announced On
3/2/2006
Transaction Type
M&A
Amount
$273,000,000
M&A Terms
Applied Biosystems Group (NYSE: ABI), an Applera Corporation business, and Ambion, Inc. today announced they have signed a definitive agreement whereby Applied Biosystems will acquire the Research Products Division of Ambion, a premium supplier of RNA-based reagents for life science research and drug development, for approximately $273 million in cash.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2130 Woodward St.
Austin, TX 78744
USA
Austin, TX 78744
USA
Phone
Website
Email Address
Overview
Ambion is a market leader in the development and supply of innovative RNA-based life science research and molecular biology products. Ambion specializes in the development of products for stabilizing, synthesizing, handling, isolating, storing, detecting, and measuring RNA.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matt Winkler
Browse more venture capital transactions:
Prev: 3/2/2006: ARCA Discovery venture capital transaction
Next: 3/6/2006: OpTier venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs